Byakangelicin protects against carbon tetrachloride–induced liver injury and fibrosis in mice

Liver fibrosis is a disease caused by long‐term damage that is related to a number of factors. The current research on the treatment of liver fibrosis mainly focuses on the activation of hepatic stellate cell, in addition to protecting liver cells. byakangelicin has certain anti‐inflammatory ability...

Full description

Saved in:
Bibliographic Details
Published in:J Cell Mol Med
Main Authors: Li, Xiaohe, Shao, Shuaibo, Li, Hailong, Bi, Zhun, Zhang, Shanshan, Wei, Yiying, Bai, Jiakun, Zhang, Ruotong, Ma, Xiaoyang, Ma, Bowei, Zhang, Liang, Xie, Chunfeng, Ning, Wen, Zhou, Honggang, Yang, Cheng
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2020
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7412405/
https://ncbi.nlm.nih.gov/pubmed/32643868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15493
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items